Skip to main content
Premium Trial:

Request an Annual Quote

Mayo Florida Lands $5M for New Individualized Medicine Clinic

NEW YORK (GenomeWeb News) – Mayo Clinic in Florida said today that it has received a $5 million private donation to help fund the launch and operations of a new clinical center in Jacksonville that will use genomic technologies to tailor treatments to individual patients.

The new Individualized Medicine Clinic in Jacksonville will be a component of Mayo Clinic's broader Center for Individualized Medicine, a program that also spans Mayo's operations in Minnesota and Arizona, and harnesses a range of resources, including genome sequencing, proteomics, biobanking, and gene expression facilities, among others.

In the new program, a team at the Jacksonville center that includes genomics scientists, genetic counselors, bioinformatics experts, and bioethicists, will work with physicians to determine whether specific patients are good candidates for treatments guided by genetic testing.

This multidisciplinary group will provide consulting for cancer patients who have seen standard treatments fail and for patients with "diagnostic odyssey" cases, disorders that are complex or difficult to diagnose but which appear to be genetic in origin, Mayo said.

The new funding was provided by the Cecilia and Dan Carmichael family, who in 2008 established the Mayo Clinic Carmichael Family Endowed Fund for Individualized Breast Cancer Medicine and helped to fund the Breast Clinic at Mayo Clinic.

Mayo's Center for Individualized Medicine has translational programs focused on biomarker discovery, clinical genomics, epigenomics, pharmacogenomics, and the microbiome, and infrastructure programs that include a medical genomics facility, biorepositories, bioinformatics resources, as well as bioethics and education and training components.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.